Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.

The Journal of Infectious Diseases
C W Norden

Abstract

Levels of rifampin, gentamicin, sisomicin, and cephalothin in normal and osteomyelitic rabbit bones were measured, and the efficacy of these drugs in the treatment of osteomyelitis was evaluated. Single drug regimens, including rifampin for 14 days and gentamicin, sisomicin, and cephalothin each for 28 days, were relatively ineffective (5%-33% sterile bone cultures). Rifampin, administered for 28 days, sterilized the bones of 55% of treated animals. The combination of gentamicin and rifampin, given for either 14 or 28 days, sterilized the bones of 67% of treated animals. The combinations of rifampin plus sisomicin and of rifampin plus cephalothin, given for 28 days, were significantly more effective than these agents alone, sterilizing 90%-95% of bones. The combination of rifampin, sisomicin, and cephalothin, given for only 14 days, sterilized the bones of all treated rabbits. Staphylococci isolated from the bones of therapeutic failures that had received rifampin alone or in combination with other antibiotics were highly resistant to rifampin (minimal inhibitory concentration, greater than 250 mug/ml), whereas the organisms recovered from animals not receiving rifampin remained sensitive. Results of in vitro studies of synergy...Continue Reading

Citations

Jan 1, 1984·Archives of Orthopaedic and Trauma Surgery·Y MirovskyL Copeliovitch
Jul 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Carbon
Jan 1, 1990·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·K W WongK R Kenyon
Nov 27, 2008·Archives of Orthopaedic and Trauma Surgery·Tang HuiDing Jing
Dec 20, 2008·Current Infectious Disease Reports·Saima Aslam, Rabih O Darouiche
Aug 14, 1980·The New England Journal of Medicine·F A Waldvogel, P S Papageorgiou
Oct 21, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert W FinbergMichael J Rybak
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·D R Moorman, G L Mandell
Apr 1, 1983·Antimicrobial Agents and Chemotherapy·M Maduri TraczewskiP Murphy
May 1, 1992·Antimicrobial Agents and Chemotherapy·B Fantin, C Carbon
May 1, 1995·Antimicrobial Agents and Chemotherapy·J BlaserW Zimmerli
Nov 1, 1996·The American Journal of Medicine·D W Haas, M P McAndrew
Jun 28, 1985·The American Journal of Medicine·J T Mader
Dec 1, 2014·Journal of Experimental Orthopaedics·Brian D MarianiRocky S Tuan
Jan 20, 2006·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J Kent EllingtonRobert Sherertz
Jan 1, 1988·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·M MacMillanL Hendeles
Jan 1, 1978·The Journal of Pediatrics·T R TetzlaffJ Larrondo
Sep 30, 2017·The Journal of Antimicrobial Chemotherapy·Mercedes Gonzalez MorenoMariagrazia Di Luca
Jan 26, 1999·Clinical Orthopaedics and Related Research·E L Pesanti, J A Lorenzo
Oct 16, 2004·The Journal of Antimicrobial Chemotherapy·Ashraf A KadryMohsen A Bayomi
Jan 1, 1985·Scandinavian Journal of Infectious Diseases·W ZimmerliK Vosbeck
Oct 1, 1984·Orthopedics·G H Karam
Sep 24, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M Musher, Reuben J Arasaratnam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.